Publication Date
| In 2025 | 0 |
| Since 2024 | 1 |
| Since 2021 (last 5 years) | 1 |
| Since 2016 (last 10 years) | 1 |
| Since 2006 (last 20 years) | 2 |
Descriptor
| Control Groups | 2 |
| Screening Tests | 2 |
| COVID-19 | 1 |
| Comparative Analysis | 1 |
| Drug Abuse | 1 |
| Drug Therapy | 1 |
| Eligibility | 1 |
| Enrollment | 1 |
| Ethics | 1 |
| Experimental Groups | 1 |
| Instructional Effectiveness | 1 |
| More ▼ | |
Source
| Research Ethics | 1 |
| Substance Abuse | 1 |
Author
| Anna Bryan | 1 |
| Dewey, Charlene M. | 1 |
| Ghulyan, Marine V. | 1 |
| Jane Bryce | 1 |
| Kathryn Mears | 1 |
| Melanie Arnold | 1 |
| Stacie Merritt | 1 |
| Swiggart, William H. | 1 |
Publication Type
| Journal Articles | 2 |
| Reports - Descriptive | 2 |
Education Level
| Higher Education | 1 |
Audience
Location
Laws, Policies, & Programs
Assessments and Surveys
What Works Clearinghouse Rating
Peer reviewed
Direct linkMelanie Arnold; Stacie Merritt; Kathryn Mears; Anna Bryan; Jane Bryce – Research Ethics, 2024
This article describes our efforts to screen and enrol clinical trial participants conscientiously in the COVID-19 pandemic setting. We present the standard screening and enrolment process prior to, and our process of adapting to, the pandemic. Our goal was to develop a way to screen and enrol people for clinical trials that was both equitable and…
Descriptors: COVID-19, Pandemics, Experimental Groups, Control Groups
Swiggart, William H.; Ghulyan, Marine V.; Dewey, Charlene M. – Substance Abuse, 2012
Controlled prescription drug (CPD) abuse is an increasing threat to patient safety and health care providers (HCPs) are not adequately prepared nor do they routinely employ proper screening techniques. Using standardized patients (SPs) as an instructional strategy, the trained physicians on proper prescribing practices and SBIRT (Screening, Brief…
Descriptors: Medical Education, Physicians, Patients, Drug Abuse
